Atlas Trials

Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients

Clinical trial NCT01117662 · TERMINATED

Trial details

NCT number
NCT01117662
Sponsor
Hannover Medical School
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Rejection
Start date
2012-05-01
Primary completion
2016-05-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.